CANVAC JUNIOR
CANVAC JUNIOR
Authorised
- Canine parvovirus, strain T-86, Live
- Canine distemper virus, strain Onderstepoort, Live
Product identification
Medicine name:
CANVAC JUNIOR
Active substance:
- Canine parvovirus, strain T-86, Live
- Canine distemper virus, strain Onderstepoort, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain T-86, Live1024.00/haemagglutinating units1.00millilitre(s)
-
Canine distemper virus, strain Onderstepoort, Live4.00/log 10 50% embryo infective dose1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AH
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dyntec spol. s r.o.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 130115
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 18/05/2022